An interventional study of Normal sleep and Partial sleep deprivation in Physical Activity, Energy Intake and Appetite, sponsored by National Taiwan Normal University. Not yet recruiting. Open to male participants aged 20 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-06.
Sponsored by National Taiwan Normal University · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Motor Activity by National Taiwan Normal University — 3 open to participants now, 3 under way, none of them phase 3. Motor Activity · National Taiwan Normal University.
Among the 12 studies in Motor Activity by National Taiwan Normal University, this one is the 4th largest by planned enrollment, is the only one that started in 2026, is one of 12 with no phase, and was the 11th registered.
9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.
Browse Motor Activity studies →3 of the 12 studies in Motor Activity by National Taiwan Normal University are open now, in 1 country. Recruiting first, the newest first:
National Taiwan Normal University · Sites in Taiwan
Ages 20–50 · Healthy volunteers
National Taiwan Normal University · Sites in Taiwan
Ages 20–50 · Healthy volunteers
By country, each count listing its studies:
Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.
This study: 20 Years to 45 Years · male · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 1 started in 2026.
This study's planned enrollment of 48 is below the median of 60 across 8,412 interventional studies indexed under Motor Activity.
Median enrollment 35 across the 12 interventional studies. Of the 7 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
National Taiwan Normal University is the lead sponsor of 64 studies on the registry; 15 are open to participants now.
1 of the studies in Motor Activity by National Taiwan Normal University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07393607National Taiwan Normal UniversityEffects of Acute Sleep Deprivation on Human Behaviours | 2027-03-01 |
Add it to your calendar (.ics) → With an account.
Among the 12 studies in Motor Activity by National Taiwan Normal University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study will investigate whether acute sleep deprivation affects appetite, eating behavior, and physical activity in both regular exercisers and physically inactive individuals.
Prior to the main trials, participants will complete assessments of V̇O2max and maximal muscle strength within 7 to 14 days before the main trials. They will also record one week of daily physical activity, sleep patterns, and diet (including two weekdays and one weekend day) to ensure they meet the inclusion criteria.
Participants will be healthy males aged 20 to 45, grouped according to their habitual activity levels.
Day 1:
Physical activity is restricted to a minimum, with no exercise permitted. Participants are allowed to eat freely before 15:00; however, all food intake will be recorded to enable replication prior to the subsequent main trial. Napping is not permitted. Participants will arrive at the laboratory between 18:30 and 19:00. Subjective appetite sensations and food preferences will be assessed. Participants will have either an 8-hour sleep opportunity in the laboratory from 23:00 to 07:00 (i.e., normal sleep trial) or a 3-hour sleep opportunity from 03:00 to 07:00 (i.e., partial sleep deprivation trial).
Day 2:
Participants will wake at 07:00. After completing personal hygiene, they will rest for 20 minutes to ensure full alertness. At 07:30, a 20-minute resting metabolic rate assessment will be conducted, alongside the collection of heart rate variability and muscle oxygen saturation data. Subsequently, pulse wave velocity measurement, cognitive function tests, subjective questionnaires, and a computerized food preference test will be administered.
After the baseline assessment, a 3-hour oral glucose tolerance test (OGTT) will be administered. Visual analogue scale assessments-including sleep, appetite, and mood-will be conducted every 30 minutes during the OGTT. Food preferences will be measured 180 minutes after the completion of the OGTT. Upon leaving the laboratory, participants will be provided with a pedometer and wearable devices and instructed to record dietary intake (using a food scale and photographic records), sleep, and glucose values on the experimental day and for the following four consecutive days.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will have an 8-hour sleep opportunity in the lab from 23:00 to 07:00.
Behavioral: Normal sleep
Participants will have a 3-hour sleep opportunity in the lab from 03:00 to 07:00.
Behavioral: Partial sleep deprivation
Participants will have an 8-hour sleep opportunity in the lab from 23:00 to 07:00.
Participants will have a 3-hour sleep opportunity in the lab from 03:00 to 07:00.
Energy intake
Energy and macronutrients intake will be collected using pictures and via a food scale
Time frame: 4 days in a free-living conditions.
Physical activity
Physical activity level and intensity will be collected using wearable devices
Time frame: 4 days in a free-living conditions.
Food preference
Computerised subjective food choice
Time frame: Baseline and at the end of the 3-hour oral glucose tolerance test (OGTT).
Appetite sensations
Subjective appetitive feelings will be measured using a 0-100 mm visual analog scale (VAS), with higher values indicating more intense feelings.
Time frame: At 0 (baseline), 30, 60, 90, 120, 150, and 180 minutes during the 3-hour oral glucose tolerance test (OGTT).
Mood sensations
Subjective mood feelings will be measured using a 0-100 mm visual analog scale (VAS), with higher values indicating more intense feelings.
Time frame: At 0 (baseline), 30, 60, 90, 120, 150, and 180 minutes during the 3-hour oral glucose tolerance test (OGTT).
Sleep sensations
Subjective sleep feelings will be measured using a 0-100 mm visual analog scale (VAS), with higher values indicating more intense feelings.
Time frame: At 0 (baseline), 30, 60, 90, 120, 150, and 180 minutes during the 3-hour oral glucose tolerance test (OGTT).
Sleep
Sleep duration will be collected via wearable device.
Time frame: 4 days in a free-living conditions.
Glucose responses
Clucose responses will be collected using continuous glucose monitoring
Time frame: 4 days in a free-living conditions.
No study locations are listed for this record.
Start is estimated for Mar 2026; primary completion for Mar 2027, 12 months later.
Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 12 months is below that.
Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Taiwan Normal University